FDA
approval
· 2017-03-21
FDA Approved: XADAGO — Original Application (MDD US Operations LLC, a subsidiary of Supernus Pharmaceuticals, Inc.)
Summary
FDA approved XADAGO (safinamide mesylate) in an Original Application for Parkinson's disease. The applicant/manufacturer is MDD US Operations LLC, a subsidiary …
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for XADAGO (SAFINAMIDE MESYLATE)